NASDAQ$INO

Inovio Pharmaceuticals Inc · Q3 2014 earnings

Q3 2014 earnings · · Investor relations

Headline financials

Total Revenue

$1.8M

Previous: $9.49M-81.0%
EPS (adj)

-$1.44

Previous: -$1.92+25.0%
Capital Expenditures

$321K

Previous: $184K+73.8%
Free Cash Flow

-$8.36M

Previous: -$5.89M-42.0%
Net Income

-$7.18M

Previous: -$30.9M+76.8%
Operating Income

-$8.33M

Previous: $766K-1188.1%
Gross Profit

-$5.18M

Previous: $4.05M-227.9%
Cash & Equivalents

$70.7M

Previous: $33.1M+113.7%
Total Assets

$135M

Previous: $88M+52.9%
Stock-Based Comp

$796K

Previous: $545K+46.1%

Revenue & EPS history

Inovio · Revenue · Quarterly

$1.8M

Q3 2014-81%vs Q3 2013
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-1.6%

Avg return

Earnings day

-0.6%

Avg return

5 days after

-5.5%

Avg return

30 days after

39%

25 / 64 earnings

Positive

+21.6%

Q4 2014

Best reaction

-27.8%

Q2 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.3%-13.5%
Q4 2025-1.2%-1.2%-36.9%
Q3 2025-7.1%-4.7%-0.9%
Q1 2025-1.6%+7.8%+4.2%
Q4 2024-6.7%-10.5%-17.1%
Q3 2024-13.9%-18.6%-53.1%
Q2 2024-1.7%-8.1%-26.9%
Q1 2024+7.2%+12.7%-11.0%
Q4 2023-6.7%+24.4%+21.9%
Q3 2023-7.9%+0.0%+0.0%
Q2 2023+9.5%+9.5%+7.1%
Q1 2023-7.1%-8.3%-38.1%
Q4 2022+3.2%-4.0%-34.9%
Q3 2022+1.4%+9.3%-14.4%
Q2 2022+10.2%+11.4%-8.5%
Q1 2022-23.6%-16.0%-30.4%
Q4 2021-5.9%-4.0%+10.8%
Q3 2021+5.6%+9.1%-7.0%
Q2 2021-5.9%+1.3%-9.2%
Q1 2021-5.3%-4.4%+46.4%
Q4 2020-9.7%-17.2%-16.4%
Q3 2020+9.3%+6.6%+8.5%
Q2 2020-27.7%-26.9%-49.2%
Q1 2020+18.8%+23.7%+23.3%
Q4 2019-14.0%-12.3%-3.0%
Q3 2019-5.7%-4.1%+10.6%
Q2 2019-1.6%-6.3%-15.8%
Q1 2019-4.4%-9.2%-37.2%
Q4 2018+3.7%+0.0%+15.9%
Q3 2018+1.1%-7.5%-1.3%
Q2 2018+14.3%+13.8%+35.5%
Q1 2018-6.2%+1.1%-5.1%
Q4 2017+6.6%+12.6%+11.5%
Q3 2017-16.6%-14.3%-15.3%
Q2 2017-0.2%-1.4%+7.8%
Q1 2017+5.8%+15.2%+27.0%
Q4 2016-6.1%-7.7%-7.9%
Q3 2016+18.7%+26.8%+8.7%
Q2 2016-8.1%-9.1%-8.1%
Q1 2016+4.7%
Q4 2015-4.9%
Q3 2015+3.1%
Q2 2015+20.5%
Q1 2015+1.1%
Q4 2014+21.6%
Q3 2014+0.6%
Q2 2014-12.9%
Q1 2014+2.8%
Q4 2013-2.0%
Q3 2013-1.1%
Q2 2013-27.8%
Q1 2013+1.6%
Q4 2012-1.9%
Q3 2012-7.6%
Q2 2012+1.9%
Q1 2012-2.0%
Q4 2011-6.5%
Q3 2011-4.8%
Q2 2011+1.7%
Q1 2011+0.0%
Q4 2010-1.8%
Q3 2010+5.9%
Q2 2010-1.1%
Q1 2010-7.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro